In vitro methods to assess 11β-hydroxysteroid dehydrogenase type 1 activity

Manuel Kley1, Seraina O Moser1, Denise V Winter2

  • 1Division of Molecular and Systems Toxicology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland; Swiss Centre for Applied Human Toxicology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland.

Methods in Enzymology
|October 6, 2023
PubMed
Summary

This article provides a detailed overview of in vitro methods for measuring 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) activity. The enzyme converts inactive glucocorticoids into active forms and is involved in various metabolic and cognitive processes. The study outlines protocols for enzyme preparation, activity assays, and readout techniques. It includes a decision tree to guide researchers in selecting the most appropriate assay for their needs. The methods described are suitable for assessing enzyme activity in disease models, substrate kinetics, and inhibitor screening. The article aims to serve as a comprehensive resource for researchers working with 11β-HSD1.

Frequently Asked Questions

Related Concept Videos